Evidence map›Paper›PMID 36504614›Full record

ArticleGerms2022

Isolated anti-HBc: reflections from clinical microbiology and infectious diseases.

Hanna Rydén, Laura Ambra Nicolini, Monique I Andersson, Zeinab Nabil Ahmed Said, Malik Sallam, Gülşen Özkaya Şahin, ESCMID Study Group for Viral Hepatitis (ESGVH)

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Germs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hanna RydénMD, Department of Laboratory Medicine, Clinical Microbiology, Region Skåne, 22242 Lund, Sweden and Department of Experimental Infections Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.
Laura Ambra NicoliniMD, PhD, Infectious Diseases Unit, Ospedale Policlinico San Martino-IRCC, 16132 Genoa, Italy.
Monique I AnderssonMD, PhD, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Headington, Oxford OX3 9DU, UK and Division of Medical Virology, Stellenbosch University, Stellenbosch, South Africa.
Zeinab Nabil Ahmed SaidMD, PhD, Microbiology and Immunology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Malik SallamMD, PhD, Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan and Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan and Department of Translational Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.
Gülşen Özkaya ŞahinMD, PhD, Department of Laboratory Medicine, Clinical Microbiology, Region Skåne, 22242 Lund, Sweden and Department of Translational Medicine, Faculty of Medicine, Lund University, 22362 Malmö, Sweden.
ESCMID Study Group for Viral Hepatitis (ESGVH)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36504614
PMCPMC9719384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.